TP53 and neoplasm: These results suggest that p53 SMWC-induced activation of endogenous p53 in cells already enriched for p53 expression is shared by both primed immune cells and tumor cells, presumably leading to their toxic response to p53 SMWC, which is likely manifested as induced senescence.